- Home
- RVNC vs GUTS Comparison
RVNC vs GUTS Comparison
Compare RVNC & GUTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVNC
- GUTS
- Stock Information
- Founded
- RVNC 1999
- GUTS 2010
- Country
- RVNC United States
- GUTS United States
- Employees
- RVNC N/A
- GUTS N/A
- Industry
- RVNC Biotechnology: Pharmaceutical Preparations
- GUTS
- Sector
- RVNC Health Care
- GUTS
- Exchange
- RVNC Nasdaq
- GUTS NYSE
- Market Cap
- RVNC 320.5M
- GUTS 110.1M
- IPO Year
- RVNC 2014
- GUTS 2024
- Fundamental
- Price
- RVNC $3.09
- GUTS $1.79
- Analyst Decision
- RVNC Hold
- GUTS Buy
- Analyst Count
- RVNC 9
- GUTS 2
- Target Price
- RVNC $8.45
- GUTS $18.00
- AVG Volume (30 Days)
- RVNC 3.6M
- GUTS 292.2K
- Earning Date
- RVNC 11-07-2024
- GUTS 02-02-2025
- Dividend Yield
- RVNC N/A
- GUTS N/A
- EPS Growth
- RVNC N/A
- GUTS N/A
- EPS
- RVNC N/A
- GUTS N/A
- Revenue
- RVNC $256,945,000.00
- GUTS $97,000.00
- Revenue This Year
- RVNC $11.28
- GUTS N/A
- Revenue Next Year
- RVNC $27.21
- GUTS N/A
- P/E Ratio
- RVNC N/A
- GUTS N/A
- Revenue Growth
- RVNC 25.82
- GUTS N/A
- 52 Week Low
- RVNC $2.30
- GUTS $1.74
- 52 Week High
- RVNC $9.75
- GUTS $14.50
- Technical
- Relative Strength Index (RSI)
- RVNC 33.47
- GUTS 36.46
- Support Level
- RVNC $3.06
- GUTS $2.00
- Resistance Level
- RVNC $3.09
- GUTS $2.13
- Average True Range (ATR)
- RVNC 0.11
- GUTS 0.20
- MACD
- RVNC 0.02
- GUTS -0.05
- Stochastic Oscillator
- RVNC 6.90
- GUTS 4.76
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.
About GUTS FRACTYL HEALTH INC
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.